Association studies of excision repair cross-complementation group 1 (ERCC1) haplotypes with lung and head and neck cancer risk in a Caucasian population

Cancer Epidemiology

Volumn 35, Issue 2, 2011, Pages 175-181

  Jones, Nathan R ^a   Spratt, Thomas E ^a   Berg, Arthur S ^a   Muscat, Joshua E ^a   Lazarus, Philip ^a   Gallagher, Carla J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Caucasian; ERCC1; Genotyping; Haplotypes; Head and neck cancer; Lung cancer; Smoking

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1;

ADULT; AGED; ARTICLE; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; DNA REPAIR; DNA-BINDING PROTEINS; ENDONUCLEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING;

EID: 79953112643     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2010.08.007     Document Type: Article

References (49)

1. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999, 91(14):1194-1210.
2. Kietthubthew S., Sriplung H., Au W.W., Ishida T. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int J Hyg Environ Health 2006, 209(1):21-29.
3. Shen H., Spitz M.R., Qiao Y., Guo Z., Wang L.E., Bosken C.H., et al. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer 2003, 107(1):84-88.
4. Bessho T., Sancar A., Thompson L.H., Thelen M.P. Reconstitution of human excision nuclease with recombinant XPF-ERCC1 complex. J Biol Chem 1997, 272(6):3833-3837.
5. Araujo S.J., Wood R.D. Protein complexes in nucleotide excision repair. Mutat Res 1999, 435(1):23-33.
6. Tsodikov O.V., Enzlin J.H., Scharer O.D., Ellenberger T. Crystal structure and DNA binding functions of ERCC1, a subunit of the DNA structure-specific endonuclease XPF-ERCC1. Proc Natl Acad Sci U S A 2005, 102(32):11236-11241.
7. Bryant H.E., Ying S., Helleday T. Homologous recombination is involved in repair of chromium-induced DNA damage in mammalian cells. Mutat Res 2006, 599:116.
8. Mu D., Bessho T., Nechev L.V., Chen D.J., Harris T.M., Hearst J.E., et al. DNA interstrand cross-links induce futile repair synthesis in mammalian cell extracts. Mol Cell Biol 2000, 20(7):2446-2454.
9. Bessho T., Mu D., Sancar A. Initiation of DNA interstrand cross-link repair in humans: the nucleotide excision repair system makes dual incisions 5′ to the cross-linked base and removes a 22- to 28-nucleotide-long damage-free strand. Mol Cell Biol 1997, 17(12):6822-6830.
10. Kiyohara C., Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int J Med Sci 2007, 4(2):59-71.
11. Zienolddiny S., Campa D., Lind H., Ryberg D., Skaug V., Stangeland L., et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006, 27(3):560-567.
12. Zhou W., Liu G., Park S., Wang Z., Wain J.C., Lynch T.J., et al. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2005, 14(2):491-496.
13. Weiss J.M., Weiss N.S., Ulrich C.M., Doherty J.A., Voigt L.F., Chen C. Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2005, 14(11 Pt 1):2524-2530.
14. Goode E.L., Ulrich C.M., Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002, 11(12):1513-1530.
15. Cheng L., Sturgis E.M., Eicher S.A., Spitz M.R., Wei Q. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer 2002, 94(2):393-397.
16. Winsey S.L., Haldar N.A., Marsh H.P., Bunce M., Marshall S.E., Harris A.L., et al. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 2000, 60(20):5612-5616.
17. Chen P., Wiencke J., Aldape K., Kesler-Diaz A., Miike R., Kelsey K., et al. Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev 2000, 9(8):843-847.
18. Cheng L., Spitz M.R., Hong W.K., Wei Q. Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis 2000, 21(8):1527-1530.
19. Reed E., Yu J.J., Davies A., Gannon J., Armentrout S.L. Clear cell tumors have higher mRNA levels of ERCC1 and XPB than other histological types of epithelial ovarian cancer. Clin Cancer Res 2003, 9(14):5299-5305.
20. Rosell R., Cecere F., Santarpia M., Reguart N., Taron M. Predicting the outcome of chemotherapy for lung cancer. Curr Opin Pharmacol 2006, 6(4):323-331.
21. Rosell R., Taron M., Barnadas A., Scagliotti G., Sarries C., Roig B. Nucleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer. Cancer Control 2003, 10(4):297-305.
22. Shirota Y., Stoehlmacher J., Brabender J., Xiong Y.P., Uetake H., Danenberg K.D., et al. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J Clin Oncol 2001, 19(23):4298-4304.
23. Dabholkar M., Vionnet J., Bostick-Bruton F., Yu J.J., Reed E. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy. J Clin Invest 1994, 94(2):703-708.
24. Dabholkar M., Bostick-Bruton F., Weber C., Bohr V.A., Egwuagu C., Reed E. ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients. J Natl Cancer Inst 1992, 84(19):1512-1517.
25. Vogel U., Laros I., Jacobsen N.R., Thomsen B.L., Bak H., Olsen A., et al. Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat Res 2004, 546(1-2):65-74.
26. Yin J., Vogel U., Guo L., Ma Y., Wang H. Lack of association between DNA repair gene ERCC1 polymorphism and risk of lung cancer in a Chinese population. Cancer Genet Cytogenet 2006, 164(1):66-70.
27. Li Y., Gu S., Wu Q., Li Y., Fu X., Mao Y., et al. No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysis. Eur J Hum Genet 2007, 15(9):967-973.
28. Sturgis E.M., Dahlstrom K.R., Spitz M.R., Wei Q. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2002, 128(9):1084-1088.
29. Sugimura T., Kumimoto H., Tohnai I., Fukui T., Matsuo K., Tsurusako S., et al. Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med 2006, 35(1):11-18.
30. Ma H., Xu L., Yuan J., Shao M., Hu Z., Wang F., et al. Tagging single nucleotide polymorphisms in excision repair cross-complementing group 1 (ERCC1) and risk of primary lung cancer in a Chinese population. Pharmacogenet Genomics 2007, 17(6):417-423.
31. Zang E.A., Wynder E.L. Smoking trends in the United States between 1969 and 1995 based on patients hospitalized with non-smoking-related diseases. Prev Med 1998, 27(6):854-861.
32. Altshuler D., Brooks L.D., Chakravarti A., Collins F.S., Daly M.J., Donnelly P. A haplotype map of the human genome. Nature 2005, 437(7063):1299-1320.
33. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
34. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002, 70(2):425-434.
35. Dupont W.D., Plummer W.D. Power and sample size calculations. A review and computer program. Control Clin Trials 1990, 11(2):116-128.
36. Belinsky S.A., Klinge D.M., Stidley C.A., Issa J.P., Herman J.G., March T.H., et al. Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer. Cancer Res 2003, 63(21):7089-7093.
37. el-Bayoumy K., Upadhyaya P., Desai D.H., Amin S., Hoffmann D., Wynder E.L. Effects of 1,4-phenylenebis(methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, and d-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Anticancer Res 1996, 16(5A):2709-2712.
38. Gunning W.T., Kramer P.M., Lubet R.A., Steele V.E., End D.W., Wouters W., et al. Chemoprevention of benzo(a)pyrene-induced lung tumors in mice by the farnesyltransferase inhibitor R115777. Clin Cancer Res 2003, 9(5):1927-1930.
39. Keith R.L., Miller Y.E. Lung cancer: genetics of risk and advances in chemoprevention. Curr Opin Pulm Med 2005, 11(4):265-271.
40. Hansen R.D., Sorensen M., Tjonneland A., Overvad K., Wallin H., Raaschou-Nielsen O., et al. A haplotype of polymorphisms in ASE-1, RAI and ERCC1 and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: a Danish prospective case-cohort study. BMC Cancer 2008, 8:54.
41. Nexo B.A., Vogel U., Olsen A., Ketelsen T., Bukowy Z., Thomsen B.L., et al. A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55. Carcinogenesis 2003, 24(5):899-904.
42. Vogel U., Sorensen M., Hansen R.D., Tjonneland A., Overvad K., Wallin H., et al. Gene-environment interactions between smoking and a haplotype of RAI, ASE-1 and ERCC1 polymorphisms among women in relation to risk of lung cancer in a population-based study. Cancer Lett 2007, 247(1):159-165.
43. Schierup M.H., Mailund T., Li H., Wang J., Tjonneland A., Vogel U., et al. Haplotype frequencies in a sub-region of chromosome 19q13.3, related to risk and prognosis of cancer, differ dramatically between ethnic groups. BMC Med Genet 2009, 10:20.
44. Yin J., Vogel U., Ma Y., Qi R., Wang H. Haplotypes of nine single nucleotide polymorphisms on chromosome 19q13.2-3 associated with susceptibility of lung cancer in a Chinese population. Mutat Res 2008, 641(1-2):12-18.
45. Zhao H., Wang L.E., Li D., Chamberlain R.M., Sturgis E.M., Wei Q. Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis. Carcinogenesis 2008, 29(8):1560-1566.
46. Woelfelschneider A., Popanda O., Lilla C., Linseisen J., Mayer C., Celebi O., et al. A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients. Carcinogenesis 2008, 29(9):1758-1764.
47. Yu D., Zhang X., Liu J., Yuan P., Tan W., Guo Y., et al. Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis. Clin Cancer Res 2008, 14(9):2878-2886.
48. Austin H., Hill H.A., Flanders W.D., Greenberg R.S. Limitations in the application of case-control methodology. Epidemiol Rev 1994, 16(1):65-76.
49. McWhir J., Selfridge J., Harrison D.J., Squires S., Melton D.W. Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nat Genet 1993, 5(3):217-224.